Infinity Pharmaceuticals Inc (INFIQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2012 | 12-2011 | 12-2010 | 12-2009 | 12-2008 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 175,742 | 24,197 | 20,417 | 16,287 | 16,575 |
| Marketable Securities | 150,276 | 91,081 | 79,805 | 113,759 | 110,197 |
| Receivables | N/A | 218 | N/A | 55 | 7,457 |
| TOTAL | $329,749 | $117,981 | $103,129 | $133,613 | $136,618 |
| Non-Current Assets | |||||
| PPE Net | 4,079 | 4,582 | 5,148 | 5,694 | 5,320 |
| Investments And Advances | 617 | 659 | 737 | 691 | 0 |
| Other Non-Current Assets | 1,215 | 1,268 | 15,553 | 17,320 | 18,679 |
| TOTAL | $5,911 | $6,509 | $21,437 | $23,705 | $24,000 |
| Total Assets | $335,660 | $124,490 | $124,566 | $157,318 | $160,618 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 8,604 | 5,952 | 2,606 | 1,441 | 2,759 |
| Accrued Expenses | 10,059 | 18,819 | 20,364 | 8,549 | 11,563 |
| TOTAL | $18,663 | $28,986 | $27,751 | $14,205 | $16,031 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 37,553 | N/A | N/A | N/A |
| Deferred Revenues | N/A | 4,215 | 4,780 | 4,214 | 1,703 |
| Other Non-Current Liabilities | 6,792 | 371 | 970 | 2,225 | 2,340 |
| TOTAL | $6,792 | $80,071 | $47,332 | $52,801 | $24,291 |
| Total Liabilities | $25,455 | $109,057 | $75,082 | $67,006 | $40,322 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 47,645 | 26,760 | 26,546 | 26,263 | 26,133 |
| Common Shares | 48 | 27 | 27 | 26 | 24 |
| Retained earnings | -323,016 | -269,052 | -229,010 | -180,026 | -148,892 |
| Other shareholders' equity | 134 | 22 | 54 | 37 | 715 |
| TOTAL | $310,205 | $15,433 | $49,484 | $90,312 | $120,296 |
| Total Liabilities And Equity | $335,660 | $124,490 | $124,566 | $157,318 | $160,618 |